Glass House Brands (GLAS) Cash & Current Investments (2020 - 2026)

Glass House Brands' (GLAS) quarterly Cash & Current Investments came in at $27.9 million in Q1 2026, down 25.76% year-on-year from $37.6 million in Q1 2025, and up 40.69% on a QoQ basis from $19.8 million in Q4 2025.

Glass House Brands (GLAS) Cash & Current Investments (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Cash & Current Investments data on file, last reported at $27.9 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 25.76% year-over-year to $27.9 million in Q1 2026; TTM through Mar 2026 was $27.9 million, a 25.76% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 46.24% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $27.9 million, up from $19.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for GLAS reached as high as $44.2 million in Q2 2025 and fell as low as $14.1 million in Q4 2022.
  • Historically, Cash & Current Investments has averaged $28.9 million across 5 years, with a median of $27.9 million in 2026.
  • Across the five-year window, Cash & Current Investments sank 92.54% in 2022 and surged 129.96% in 2023, its largest moves.
  • Year by year, Cash & Current Investments stood at $14.1 million in 2022, then jumped by 129.96% to $32.5 million in 2023, then climbed by 13.53% to $36.9 million in 2024, then plunged by 46.24% to $19.8 million in 2025, then soared by 40.69% to $27.9 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $27.9 million in Q1 2026, $19.8 million in Q4 2025, and $29.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 27.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.93 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 29.77 Mn
Jun 30, 2025 44.20 Mn
Mar 31, 2025 37.62 Mn
Dec 31, 2024 36.92 Mn
Sep 30, 2024 38.06 Mn
Jun 30, 2024 28.88 Mn
Mar 31, 2024 27.41 Mn
Dec 31, 2023 32.52 Mn
Sep 30, 2023 40.89 Mn
Jun 30, 2023 25.69 Mn
Mar 31, 2023 19.37 Mn
Dec 31, 2022 14.14 Mn
Sep 30, 2022 20.54 Mn
Jun 30, 2022 20.45 Mn
Mar 31, 2022 27.83 Mn
Dec 31, 2021 54.07 Mn
Sep 30, 2021 28.86 Mn
Jun 30, 2021 134.28 Mn